Compare, Analyse Orchid Chemicals with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ADCOCK INGRAM (S. Africa) - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   ADCOCK INGRAM
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ADCOCK INGRAM
Jun-14
ORCHID PHARMA LTD/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs194349-   
Low Rs35252-   
Sales per share (Unadj.) Rs276.5103.7-  
Earnings per share (Unadj.) Rs-79.2-26.1-  
Cash flow per share (Unadj.) Rs-43.5-21.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.981.4-  
Shares outstanding (eoy) m70.45168.78-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.9 14.3%   
Avg P/E ratio x-1.4-11.5 12.6%  
P/CF ratio (eoy) x-2.6-13.9 19.0%  
Price / Book Value ratio x2.13.7 57.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,06750,658 15.9%   
No. of employees `0002.84.3 65.2%   
Total wages/salary Rs m2,5273,179 79.5%   
Avg. sales/employee Rs Th6,956.14,078.4 170.6%   
Avg. wages/employee Rs Th902.5740.6 121.9%   
Avg. net profit/employee Rs Th-1,993.0-1,027.7 193.9%   
INCOME DATA
Net Sales Rs m19,47717,508 111.2%  
Other income Rs m407123 332.1%   
Total revenues Rs m19,88417,631 112.8%   
Gross profit Rs m1,103-3,034 -36.3%  
Depreciation Rs m2,519756 333.4%   
Interest Rs m5,227474 1,102.1%   
Profit before tax Rs m-6,236-4,141 150.6%   
Minority Interest Rs m20-12 -170.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125259 -48.4%   
Profit after tax Rs m-5,580-4,412 126.5%  
Gross profit margin %5.7-17.3 -32.7%  
Effective tax rate %2.0-6.2 -32.1%   
Net profit margin %-28.7-25.2 113.7%  
BALANCE SHEET DATA
Current assets Rs m11,01412,823 85.9%   
Current liabilities Rs m32,0607,215 444.4%   
Net working cap to sales %-108.132.0 -337.3%  
Current ratio x0.31.8 19.3%  
Inventory Days Days95111 85.5%  
Debtors Days Days34124 27.1%  
Net fixed assets Rs m29,4407,475 393.9%   
Share capital Rs m70581 866.7%   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,80013,742 27.7%   
Long term debt Rs m9,0184,829 186.7%   
Total assets Rs m46,51025,960 179.2%  
Interest coverage x-0.2-7.7 2.5%   
Debt to equity ratio x2.40.4 675.3%  
Sales to assets ratio x0.40.7 62.1%   
Return on assets %-0.8-15.2 5.0%  
Return on equity %-146.9-32.1 457.4%  
Return on capital %-3.7-19.8 18.9%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,6821,494 112.5%  
From Investments Rs m-9,860-459 2,148.8%  
From Financial Activity Rs m6,6444,383 151.6%  
Net Cashflow Rs m-1,5355,418 -28.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.81 Rs / ZAR

Compare ORCHID PHARMA LTD With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA LTD With: AUROBINDO PHARMA  VENUS REMEDIES  DR. REDDYS LAB  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Key Q2FY20 Results, BHEL Stake Sale, and Top Cues in Focus Today(Pre-Open)

On Friday, Indian share markets traded on a positive note most of the day and ended higher. The BSE Sensex logged total gains of 1,417 points in the past six sessions.

Related Views On News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS